Attention deficit hyperactivity disorder: guidelines for investigating efficacy of pharmacological intervention-Reference-Cited by-同舟云学术

Attention deficit hyperactivity disorder: guidelines for investigating efficacy of pharmacological intervention

Published:2003-08 Issue:4 Volume:13 Page:297-304
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Buitelaar J.K.,Montgomery S.A.,van Zwieten-Boot B.J.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Clinical Neurology,Neurology,Pharmacology

Reference45 articles.

1. Achenbach, T.M., 1991a. Integrative Guide for the 1991 CBCL/4-18, YSF, TRF profiles. Department of Psychiatry, University of Vermont, Burlington, VT.

2. Achenbach, T.M., 1991b. Manual for the Child Behavior Checklist/4-18 and 1991 profile. Department of Psychiatry, University of Vermont, Burlington, VT.

3. Achenbach, T.M., 1991c. Manual for the Teacher’s Report Form and 1991 profile. Department of Psychiatry, University of Vermont, Burlington, VT.

4. Historical development and present status of the schedule for affective disorders and schizophrenia for school-age children (K-SADS);Ambrosini;J. Am. Acad. Child Adolesc. Psychiatry,2000

5. Comorbidity;Angold;J. Child Psychol. Psychiatry,1999

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Investigation of French Maritime Pine Bark Extract on Attention-Deficit Hyperactivity Disorder as compared to Methylphenidate and Placebo: Part 1: Efficacy in a Randomised Trial;Journal of Functional Foods;2022-10

2. A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder;Journal of Clinical Psychopharmacology;2021-05-08

3. Efficacy and Safety of Polyunsaturated Fatty Acids Supplementation in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents: A Systematic Review and Meta-Analysis of Clinical Trials;Nutrients;2021-04-08

4. Translating Attention-Deficit/Hyperactivity Disorder Rating Scale-5 and Weiss Functional Impairment Rating Scale-Parent Effectiveness Scores into Clinical Global Impressions Clinical Significance Levels in Four Randomized Clinical Trials of SPN-812 (Viloxazine Extended-Release) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder;Journal of Child and Adolescent Psychopharmacology;2021-04-01

5. A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children;Clinical Therapeutics;2020-08